Imagine stepping into an original D&D setting that’s been lovingly written and DM’d by Tim Burton or Shel Silverstein. Instead of elves and dwarves, you have a giant card shop that’s also a person, a ...
Mary Hall is a editor for Investopedia's Advisor Insights, in addition to being the editor of several books and doctoral papers. Mary received her bachelor's in English from Kent State University with ...
This article introduces practical methods for evaluating AI agents operating in real-world environments. It explains how to ...
随着自然语言处理(NLP)技术在电子邮件安全领域的广泛应用,基于语义分析和上下文理解的检测模型已成为抵御网络钓鱼攻击的核心防线。然而,威胁行为者正迅速适应这一技术变革,开发出针对性的对抗性攻击手段。本文基于KnowBe4威胁情报团队对40起新兴攻击案例的深度分析,系统研究了“噪声注入”(Noise Injection)这一新型混淆技术。该技术通过在恶意邮件底部追加大量良性文本、合法链接及HTML换 ...
During an investigation into exposed OpenWebUI servers, the Cybernews research team identified a malicious campaign targeting vulnerable OpenWebUI servers with cryptocurrency miners and Info Stealers.
Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company aims to ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...